Literature DB >> 12444131

Dominant TCR-alpha requirements for a self antigen recognition in humans.

Stefania Mantovani1, Belinda Palermo, Silvia Garbelli, Rita Campanelli, Gioacchino Robustelli Della Cuna, Roberto Gennari, Federica Benvenuto, Erica Lantelme, Claudia Giachino.   

Abstract

TCR-alpha and -beta chains are composed of somatically rearranged V, D, and J germline-encoded gene segments that confer Ag specificity. Recent crystallographic analyses revealed that TCR-alpha has more contacts with peptide than TCR-beta, suggesting the possibility that peptide recognition predominantly relies on TCR-alpha. T cells specific for the self Ag Melan-A/MART-1 possess an exceptionally high precursor frequency in human histocompatibility leukocyte Ag-A2 individuals. This provided a unique situation for assessment of the structural relationship between TCR and peptide/MHC ligand at both the pre- and postimmune levels. Molecular and phenotypic analysis of many different Melan-A-specific T cell populations revealed that a structural constraint is imposed on the TCR for engagement with Melan-A peptides presented by HLA-A2, namely the highly preferential use of a particular TCRAV segment, AV2. Examination of CD8 single-positive thymocytes indicated that this preferential use in forming the Melan-A-specific TCR is mainly imposed by intrathymic positive selection. Our data demonstrate a dominant function of TCRAV2 segment in forming the TCR repertoire specific for the human self Ag Melan-A/MART-1 and support the view that Ag recognition is mediated predominantly by TCR-alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444131     DOI: 10.4049/jimmunol.169.11.6253

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

2.  CD28neg. T lymphocytes of a melanoma patient harbor tumor immunity and a high frequency of germline-encoded and public TCRs.

Authors:  Hisayoshi Hashimoto; Marco Sterk; Karin Schilbach
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

3.  Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.

Authors:  Laura A Johnson; Bianca Heemskerk; Daniel J Powell; Cyrille J Cohen; Richard A Morgan; Mark E Dudley; Paul F Robbins; Steven A Rosenberg
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

4.  Transgenic mice with a diverse human T cell antigen receptor repertoire.

Authors:  Liang-Ping Li; J Christoph Lampert; Xiaojing Chen; Catarina Leitao; Jelena Popović; Werner Müller; Thomas Blankenstein
Journal:  Nat Med       Date:  2010-08-08       Impact factor: 53.440

5.  T-cell receptor Valpha spectratype analysis of a CD4-mediated T-cell response against minor histocompatibility antigens involved in severe graft-versus-host disease.

Authors:  Christine G DiRienzo; George F Murphy; Stephen C Jones; Robert Korngold; Thea M Friedman
Journal:  Biol Blood Marrow Transplant       Date:  2006-08       Impact factor: 5.742

6.  Anatomically distinct fibroblast subsets determine skin autoimmune patterns.

Authors:  Zijian Xu; Daoming Chen; Yucheng Hu; Kaiju Jiang; Huanwei Huang; Yingxue Du; Wenbo Wu; Jiawen Wang; Jianhua Sui; Wenhui Wang; Long Zhang; Shuli Li; Chunying Li; Yong Yang; Jianmin Chang; Ting Chen
Journal:  Nature       Date:  2021-12-15       Impact factor: 49.962

7.  Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy.

Authors:  Belinda Palermo; Silvia Garbelli; Stefania Mantovani; Claudia Giachino
Journal:  J Autoimmune Dis       Date:  2005-08-31

8.  Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.

Authors:  Federico Serana; Alessandra Sottini; Luigi Caimi; Belinda Palermo; Pier Giorgio Natali; Paola Nisticò; Luisa Imberti
Journal:  J Transl Med       Date:  2009-03-24       Impact factor: 5.531

9.  T-cell clonotypes in cancer.

Authors:  Per Thor Straten; David Schrama; Mads Hald Andersen; Jürgen C Becker
Journal:  J Transl Med       Date:  2004-04-08       Impact factor: 5.531

10.  T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.

Authors:  Amandine Bovay; Vincent Zoete; Garry Dolton; Anna M Bulek; David K Cole; Pierre J Rizkallah; Anna Fuller; Konrad Beck; Olivier Michielin; Daniel E Speiser; Andrew K Sewell; Silvia A Fuertes Marraco
Journal:  Eur J Immunol       Date:  2017-12-11       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.